Glenmark Sinks GSK Malaria Drug Patent In UK Court
“Judgment has today been handed down in the case [which] involved the revocation of Glaxo’s patent for its anti-malarial product Malarone,” Glenmark said in a statement. “Following proceedings in the high court, Mr. Justice [Richard] Arnold revoked Glaxo’s patent.”
Malarone is the brand name...
To view the full article, register now.